Traitement de fond de l'asthme

Traitement de fond de l'asthme

1. Thomas A, Lemanske RF Jr, Jackson DJ. Approaches to stepping up and stepping down care in asthmatic patients. J Allergy Clin Immunol 2011; 128:915.

2. Nelson HS. Beta-adrenergic bronchodilators. N Engl J Med 1995; 333:499.

3. Shim C, Williams MH Jr. Bronchial response to oral versus aerosol metaproterenol in asthma. Ann Intern Med 1980; 93:428.

4. Shim C, Williams MH Jr. Comparison of oral aminophylline and aerosol metaproterenol in asthma. Am J Med 1981; 71:452.

5. Haahtela T, Järvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325:388.

6. Dutoit JI, Salome CM, Woolcock AJ. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not. Am Rev Respir Dis 1987; 136:1174.

7. Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142:832.

8. Bateman ED, Bousquet J, Keech ML, et al. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007; 29:56